Jungova, A., Stork, M., Spicka, I., Radocha, J., Minarik, J., Pavlicek, P., Mihalyova, J., Pour, L., Straub, J., Maisnar, V., Pika, T., Dekojova, T., Soukup, J., Popkova, T., Mensikova, K., Sedlák, F., Pospiskova, J., Boichuk, I., Krhovska, P., Stopka, T., Jindra, P., Jelínek, T., Knechtová, Z., Capounova, V., Latal, V., Muronova, L., Heindorfer, A., Ullrychova, J., Sykora, M., Kessler, P. and Hajek, R. (2026) “P25 | REAL-WORLD OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA: EVIDENCE SUPPORTING BORTEZOMIB–LENALIDOMIDE–DEXAMETHASONE AS A PREFERRED REGIMEN WITHOUT ANTI-CD38 ANTIBODIES”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14036.